SecBot SecBot
SC 13G/A ·Filed Nov 9, 2026

INSP

Inspire Medical Systems, Inc.
BEARISH
Impact 4/10
Horizonweeks Processed7d 10h ago SEC0001213900-26-117543
Passive stake amendment
Actionable Insight ▼ Bearish

Soleus Capital's reduction below 5% removes a passive holder from the 5%+ ownership list. Monitor for any further selling or a potential conversion to a 13D if the fund's intent changes. The filing follows the company's Q3 earnings report (November 2, 2026) which showed a 7.9% YoY revenue decline.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$62.31
T+0 close · Nov 9, 2026 · via day close
Latest settled
−0.32%
T+1 · $62.11 · next T+5 in 4h
Vs SPY
−1.64%
α at T+1
Latest observation
−2.28%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $62.31entry
  2. T+1 · 6d ago −0.32%α −1.64% · $62.11
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Soleus Capital Master Fund filed an amended Schedule 13G for Inspire Medical Systems, reporting a 4.2% stake (1,206,828 shares) as of September 30, 2026. This is a decrease from the prior filing (Soleus Capital Master Fund previously reported a 5.0%+ stake in August 2026), indicating the fund reduced its position and fell below the 5% threshold. The filing remains passive (Rule 13d-1(c)), with no activist intent.

Key Financial Metrics

Stake
4.2%
Investor
Soleus Capital Master Fund, L.P.
Investor Type
hedge fund

Key Facts

  • Soleus Capital Master Fund reported 1,206,828 shares of INSP common stock, representing 4.2% of shares outstanding as of September 30, 2026.
  • The percentage is based on 28,966,119 shares outstanding as of October 28, 2026, per the company's Form 10-Q.
  • This is a decrease from the prior filing (August 13, 2026) where Soleus held a stake above 5%, indicating the fund reduced its position and fell below the 5% threshold.
  • The filing is made under Rule 13d-1(c) (passive investor), with no intent to change or influence control.

Financial Impact

Soleus Capital reduced its INSP stake from above 5% to 4.2%, representing a reduction of at least approximately 230,000 shares (based on the prior 5%+ stake vs. current 1,206,828 shares).

ownershipdilution

Risk Factors

  • Soleus Capital may continue to reduce its position, adding selling pressure.
  • The fund's exit below 5% removes a previously supportive institutional holder.
  • The reduction comes shortly after Q3 earnings that showed a YoY revenue decline.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
38% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001213900-26-117543
Document: 0001213900-26-117543-index.html0001213900-26-117543
Document: 0001213900-26-117543.txt0001213900-26-117543

Track record

16 reports on INSP

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $59.52 Now $59.12 −0.67% settles Nov 17
  2. Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $60.54 to $61.10 Now $59.12 +2.35% ▼ −0.93% −1.29% vs SPY
  3. Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $62.31 to $62.11 Now $59.12 −5.12% ▼ −0.32% −1.64% vs SPY
  4. Nov 9, 20267d ago SC 13G/A Bearish 4/10 Viewing Entry $62.31 to $62.11 Now $59.12 +5.12% ▲ +0.32% +1.64% vs SPY
  5. Nov 2, 202614d ago 8-K Mixed 6/10 No price data
  6. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $61.90 to $66.61 Now $59.12 −4.49% ▲ +7.61% +5.96% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $68.10 to $67.21 Now $59.12 −13.19% ▼ −1.31% −0.83% vs SPY
  8. Oct 5, 20266w ago Press Release Neutral 1/10 Entry $68.20 Now $59.12 −13.31% No price data
  9. Jul 27, 202616w ago 3 Neutral 1/10 Entry $51.97 to $51.07 Now $59.12 +13.76% ▼ −1.73% −0.19% vs SPY
  10. Jul 24, 202616w ago 8-K Neutral 2/10 Entry $50.93 to $51.97 Now $59.12 +16.08% ▲ +2.04% +1.80% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026